Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
058820.KQ Stock Summary
Top 10 Correlated ETFs
058820.KQ
In the News
058820.KQ Financial details
Company Rating
Neutral
Market Cap
301.4B
Income
4.05B
Revenue
93.72B
Book val./share
1324.79
Cash/share
517.49
Dividend
-
Dividend %
-
Employees
265
Optionable
No
Shortable
Yes
Earnings
18 Mar 2021
P/E
0.04
Forward P/E
-
PEG
-0
P/S
0.03
P/B
0.02
P/C
4.3
P/FCF
0.18
Quick Ratio
1.4
Current Ratio
1.53
Debt / Equity
0.13
LT Debt / Equity
0.13
-
-
EPS (TTM)
-115.95
EPS next Y
-
EPS next Q
-
EPS this Y
-113.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
76.02%
Revenue Q/Q
-7.45%
EPS Q/Q
-29.63%
-
-
-
-
SMA20
-3.64%
SMA50
-8.15%
SMA100
3.73%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
45%
ROC
0.22%
Gross Margin
41%
Oper. Margin
16%
Profit Margin
12%
Payout
-
Shs Outstand
138.89M
Shs Float
103.01M
-
-
-
-
Target Price
-
52W Range
1993.0-2830.0
52W High
-21.38%
52W Low
+11.64%
RSI
43
Rel Volume
-
Avg Volume
499.4K
Volume
Perf Week
1.14%
Perf Month
0.45%
Perf Quarter
-
Perf Half Y
-13.76%
-
-
-
-
Beta
0.737
-
-
Volatility
17.7%, 52.51%
Prev Close
2.53%
Price
2225
Change
1.37%
058820.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 173.99 | 197.43 | 464.1 | 504.8 | 635.32 | |
Net income per share | 6.31 | 12.38 | 1.55 | 23 | -3 | |
Operating cash flow per share | 22.23 | 25.5 | 21.2 | 40.9 | 38.16 | |
Free cash flow per share | 11.95 | 13.7 | -48.28 | 12.19 | -41.51 | |
Cash per share | 24.2 | 31.13 | 790.37 | 656.4 | 601.43 | |
Book value per share | 51.55 | 59.48 | 1.3K | 1.34K | 1.43K | |
Tangible book value per share | 50.76 | 58.71 | 1.22K | 1.25K | 1.32K | |
Share holders equity per share | 51.55 | 59.48 | 1.3K | 1.34K | 1.43K | |
Interest debt per share | 0 | 0 | 3.7 | 3.86 | 52 | |
Market cap | 97.31M | 103.78M | 736.17M | 443.36M | 223.15M | |
Enterprise value | -152.64M | -376.85M | -6.82B | -3.81B | 2.48B | |
P/E ratio | 0.55 | 0.3 | 3.42 | 0.14 | -0.57 | |
Price to sales ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0 | |
POCF ratio | 0.16 | 0.14 | 0.25 | 0.08 | 0.05 | |
PFCF ratio | 0.29 | 0.27 | -0.11 | 0.26 | -0.04 | |
P/B Ratio | 0.07 | 0.06 | 0 | 0 | 0 | |
PTB ratio | 0.07 | 0.06 | 0 | 0 | 0 | |
EV to sales | -0.03 | -0.07 | -0.11 | -0.05 | 0.03 | |
Enterprise value over EBITDA | -0.28 | -0.54 | -2.16 | -0.63 | 0.42 | |
EV to operating cash flow | -0.25 | -0.52 | -2.32 | -0.68 | 0.5 | |
EV to free cash flow | -0.46 | -0.97 | 1.02 | -2.27 | -0.46 | |
Earnings yield | 1.81 | 3.37 | 0.29 | 7.14 | -1.74 | |
Free cash flow yield | 3.43 | 3.74 | -9.11 | 3.78 | -24.06 | |
Debt to equity | 0 | 0 | 0 | 0 | 0.04 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.03 | |
Net debt to EBITDA | -0.45 | -0.69 | -2.4 | -0.7 | 0.39 | |
Current ratio | 1.81 | 1.61 | 10.7 | 9.14 | 6.17 | |
Interest coverage | 0 | 0 | 79.74 | 80.23 | 195.16 | |
Income quality | 3.52 | 2.06 | 13.69 | 1.78 | -12.72 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.08 | 0.04 | 0.04 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0.05 | 0.05 | 0.04 | |
Intangibles to total assets | 0.01 | 0 | 0.06 | 0.06 | 0.07 | |
Capex to operating cash flow | -0.46 | -0.46 | -3.28 | -0.7 | -2.09 | |
Capex to revenue | -0.06 | -0.06 | -0.15 | -0.06 | -0.13 | |
Capex to depreciation | -1.42 | -1.57 | -3.96 | -1.59 | -4.51 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.01 | 0 | 0 | |
Graham number | 85.57 | 128.69 | 213.12 | 833.37 | 310.63 | |
ROIC | 0.16 | 0.22 | 0 | 0.01 | 0 | |
Return on tangible assets | 0.08 | 0.07 | 0 | 0.02 | 0 | |
Graham Net | -3.21 | -87.2 | 742.68 | 599.73 | 465.46 | |
Working capital | 364.8M | 405.61M | 132.33B | 111.75B | 113.17B | |
Tangible asset value | 1.42B | 1.66B | 169.07B | 172B | 170.57B | |
Net current asset value | -9.39M | -2.35B | 131.76B | 111.01B | 106.76B | |
Invested capital | 0 | 0 | 0 | 0 | 0.04 | |
Average receivables | 51.38M | 71.43M | 92.52M | 102.05M | 103.24M | |
Average payables | 97.55M | 114.44M | 2.85B | 5.31B | 8.14B | |
Average inventory | 20.71M | 23.83M | 7.54B | 14.12B | 17.23B | |
Days sales outstanding | 4.68 | 5.26 | 0.59 | 0.52 | 0.47 | |
Days payables outstanding | 12.61 | 11.48 | 61.37 | 51.04 | 99.39 | |
Days of inventory on hand | 2.4 | 2.59 | 165.18 | 133.7 | 188 | |
Receivables turnover | 78.07 | 69.36 | 616.84 | 697.55 | 769.06 | |
Payables turnover | 28.95 | 31.8 | 5.95 | 7.15 | 3.67 | |
Inventory turnover | 151.89 | 141.13 | 2.21 | 2.73 | 1.94 | |
ROE | 0.12 | 0.21 | 0 | 0.02 | 0 | |
Capex per share | -10.28 | -11.8 | -69.48 | -28.71 | -79.67 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 79.42 | 781.19 | 165.26 | 174.37 | 161.37 | |
Net income per share | 9.2 | -180.95 | 19.41 | 25.36 | 18.57 | |
Operating cash flow per share | 12.59 | 94.7 | -22.38 | 10.4 | 12.11 | |
Free cash flow per share | 7.62 | 10.97 | -71.84 | 9.46 | -9.22 | |
Cash per share | 28.04 | 2.79K | 636.22 | 519.18 | 517.49 | |
Book value per share | 83.25 | 6.63K | 1.35K | 1.31K | 1.32K | |
Tangible book value per share | 82.47 | 6.11K | 1.22K | 1.18K | 1.2K | |
Share holders equity per share | 83.25 | 6.63K | 1.35K | 1.31K | 1.32K | |
Interest debt per share | 0 | 240.85 | 157.24 | 174.66 | 177.1 | |
Market cap | 43.87M | 48.12M | 220.06M | 238.73M | 252.17M | |
Enterprise value | -322.75M | 2.31B | 1B | 17.34B | 20.16B | |
P/E ratio | 0.04 | 0 | 0.02 | 0.02 | 0.02 | |
Price to sales ratio | 0.02 | 0 | 0.01 | 0.01 | 0.01 | |
POCF ratio | 0.12 | 0.02 | -0.07 | 0.16 | 0.14 | |
PFCF ratio | 0.21 | 0.16 | -0.02 | 0.17 | -0.19 | |
P/B Ratio | 0.02 | 0 | 0 | 0 | 0 | |
PTB ratio | 0.02 | 0 | 0 | 0 | 0 | |
EV to sales | -0.15 | 0.11 | 0.04 | 0.68 | 0.86 | |
Enterprise value over EBITDA | -0.78 | -0.49 | 0.3 | 3.47 | 5.85 | |
EV to operating cash flow | -0.92 | 0.87 | -0.32 | 11.44 | 11.41 | |
EV to free cash flow | -1.52 | 7.53 | -0.1 | 12.57 | -14.98 | |
Earnings yield | 5.86 | -104.91 | 12.25 | 15.49 | 10.74 | |
Free cash flow yield | 4.85 | 6.36 | -45.34 | 5.78 | -5.34 | |
Debt to equity | 0 | 0.04 | 0.12 | 0.13 | 0.13 | |
Debt to assets | 0 | 0.03 | 0.09 | 0.11 | 0.11 | |
Net debt to EBITDA | -0.89 | -0.48 | 0.23 | 3.42 | 5.78 | |
Current ratio | 1.32 | 6.17 | 6.93 | 5.81 | 5.49 | |
Interest coverage | 0 | -57.61 | 46.34 | 118.57 | 68 | |
Income quality | 1.37 | -0.52 | -1.15 | 0.41 | 0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.04 | 0.03 | 0.03 | 0.03 | |
Research and developement to revenue | 0 | 0.05 | 0.04 | 0.03 | 0.01 | |
Intangibles to total assets | 0 | 0.07 | 0.07 | 0.08 | 0.08 | |
Capex to operating cash flow | -0.4 | -0.88 | 2.21 | -0.09 | -1.76 | |
Capex to revenue | -0.06 | -0.11 | -0.3 | -0.01 | -0.13 | |
Capex to depreciation | -1.95 | -4.18 | -11.71 | -0.22 | -4.81 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 131.26 | 5.2K | 767.14 | 863.49 | 743.92 | |
ROIC | 0.11 | 0 | 0 | 0.01 | 0 | |
Return on tangible assets | 0.04 | -0.03 | 0.01 | 0.02 | 0.01 | |
Graham Net | -130.06 | 2.16K | 378.33 | 250.21 | 237.5 | |
Working capital | 259.58M | 113.17B | 126.92B | 114.2B | 106.29B | |
Tangible asset value | 2.31B | 170.57B | 169.9B | 172.3B | 174.61B | |
Net current asset value | -3.41B | 106.76B | 101.3B | 87.53B | 78.96B | |
Invested capital | 0 | 0.04 | 0.12 | 0.13 | 0.13 | |
Average receivables | 77.46M | 89.08M | 86.37M | 63.43M | 66.05M | |
Average payables | 163.21M | 5.71B | 10.33B | 8.89B | 7.68B | |
Average inventory | 31.6M | 10.65B | 21.8B | 22.32B | 21.24B | |
Days sales outstanding | 2.89 | 0.44 | 0.26 | 0.22 | 0.27 | |
Days payables outstanding | 11.31 | 91.11 | 69.68 | 60.19 | 49.28 | |
Days of inventory on hand | 2.27 | 172.34 | 165.36 | 160.3 | 142.23 | |
Receivables turnover | 31.15 | 203.91 | 348.48 | 417.04 | 330.94 | |
Payables turnover | 7.96 | 0.99 | 1.29 | 1.5 | 1.83 | |
Inventory turnover | 39.57 | 0.52 | 0.54 | 0.56 | 0.63 | |
ROE | 0.11 | -0.03 | 0.01 | 0.02 | 0.01 | |
Capex per share | -4.97 | -83.73 | -49.46 | -0.94 | -21.34 |
058820.KQ Frequently Asked Questions
What is CMG Pharmaceutical Co., Ltd. stock symbol ?
CMG Pharmaceutical Co., Ltd. is a KR stock and trading under the symbol 058820.KQ
What is CMG Pharmaceutical Co., Ltd. stock quote today ?
CMG Pharmaceutical Co., Ltd. stock price is $2225 today.
Is CMG Pharmaceutical Co., Ltd. stock public?
Yes, CMG Pharmaceutical Co., Ltd. is a publicly traded company.